Amgen (AMGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://www.zacks.com/stock/news/2218010/amgen-amgn-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2218010
Jan 30, 2024 - Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Drug, Biotech Stocks' Q4 Earnings Due on Feb 6: AMGN, LLY & More
https://www.zacks.com/stock/news/2221113/drug-biotech-stocks-q4-earnings-due-on-feb-6-amgn-lly-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2221113
Feb 05, 2024 - Let's take a look at four biotech, drug companies, AMGN, LLY, GILD and EXEL, slated to release quarterly results on Feb 6.
0
Amgen Inc. (AMGN) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4668054-amgen-inc-amgn-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Feb 06, 2024 - Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q4 2023 Earnings Conference Call February 6, 2024 4:30 PM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway -...
0
Amgen (AMGN) Reports Q4 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2222222/amgen-amgn-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2222222
Feb 06, 2024 - Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Top Research Reports for NVIDIA, Visa & Amgen
https://www.zacks.com/commentary/2232860/top-research-reports-for-nvidia-visa-amgen?cid=CS-ZC-FT-research_daily-2232860
Feb 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).
0
The AI Race Gets Litigious
https://www.fool.com/investing/2024/03/09/the-ai-race-gets-litigious/?source=iedfolrf0000001
Mar 09, 2024 - We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade.
0
Novo Nordisk (NVO) Up on Upbeat Data From New Obesity Pill Study
https://www.zacks.com/stock/news/2238077/novo-nordisk-nvo-up-on-upbeat-data-from-new-obesity-pill-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238077
Mar 08, 2024 - Novo Nordisk (NVO) stock rises as it presents encouraging efficacy data on a new investigational oral obesity pill, amycretin, at its Capital Markets Day.
0
Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again
https://www.zacks.com/stock/news/2248594/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2248594
Apr 01, 2024 - Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
https://www.zacks.com/stock/news/2257263/amgen-amgn-suffers-a-larger-drop-than-the-general-market-key-insights?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2257263
Apr 17, 2024 - Amgen (AMGN) concluded the recent trading session at $264.07, signifying a -0.59% move from its prior day's close.
0
Pages: 12
<Page 2